News

Vaccines Advisory Committee to Meet on October 22

August 31, 2020

Hahn promises transparency in the review and approval of COVID-19 vaccines.

Ionis to Acquire Akcea Common Stock for $500 Million

August 31, 2020

The transaction will give Ionis access to Akcea's pipeline and commercial products, as well as its cash on hand of approximately $390 million.

FDA Expands EUA for Remdesivir

August 31, 2020

Under expanded FDA authorization, Gilead Sciences’ antiviral treatment for COVID-19 can be administered to all hospitalized patients.

Piramal Pharma Solutions to Partner with Epirium Bio

August 28, 2020

The collaboration includes an integrated program that encompasses formulation development, drug substances, and drug product manufacturing.

Axol Bioscience Appoints Liam Taylor as CEO

August 28, 2020

The company has appointed Liam Tayler as CEO to guide the growth of the company’s iPSC technologies, products, and services.

Dotmatics Launches Bioregister 2020.1

August 28, 2020

The register supports cross-functional teams of chemists and biologists in developing non-natural, chemically-modified therapeutics for drug discovery.

AbCellera’s Acquisition of OrthoMab Bispecific Platform Propels Antibody Development

August 28, 2020

AbCellera’s recent acquisition of the OrthoMab bispecific platform is expected to accelerate antibody product development.

GigaGen Highlights Research Describing New Class of Drugs for Potential COVID-19 Therapy

August 28, 2020

In the study, GigaGen presents a novel technology for producing a new class of drug, recombinant hyperimmunes, that may potentially generate new COVID-19 therapies.

Thermo Fisher and CROs Expand Access to Cryo-EM

August 28, 2020

Thermo Fisher Scientific is increasing access to cry-electron microscopy with the help of contract research organizations.

Ology Bioservices Awarded US Army Contract to Manage Production of COVID-19 Vaccines and Therapeutics

August 26, 2020

The contract is valued at $106.3 million and is supported by Operation Warp Speed.